Seminars in Hematology
Volume 45, Supplement 1 , Pages S38-S41, April 2008

Single-Dose Recombinant Activated Factor VII Therapy in Hemophilia Patients With Inhibitors

  • Gili Kenet

      Affiliations

    • Corresponding Author InformationAddress correspondence to Gili Kenet, MD, Director, Thrombosis Unit, The Israeli National Hemophilia Center, Sheba Medical Center, Tel-Hashomer, 52621, Israel.
    • ,
  • Uri Martinowitz

The Israeli National Hemophilia Center, Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel-Hashomer, Israel.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 STATEMENT OF CONFLICT OF INTEREST: Both authors have received honoraria from, and served on advisory boards for, Novo Nordisk.

PII: S0037-1963(08)00051-6

doi:10.1053/j.seminhematol.2008.03.011

Seminars in Hematology
Volume 45, Supplement 1 , Pages S38-S41, April 2008

Article Tools